Total Payments
$1,926
2024 Payments
$301.95
Companies
14
Transactions
105
Medicare Patients
4,037
Medicare Billing
$463,233
Payment Breakdown by Category
Food & Beverage$1,905 (98.9%)
Education$21.70 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,905 | 104 | 98.9% |
| Education | $21.70 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $328.36 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $312.36 | 18 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $309.40 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $208.97 | 10 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $178.75 | 8 | $0 (2019) |
| Amgen Inc. | $147.80 | 6 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $139.52 | 9 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $88.55 | 5 | $0 (2024) |
| Abbott Laboratories | $61.85 | 3 | $0 (2023) |
| Lexicon Pharmaceuticals, Inc. | $48.29 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $301.95 | 14 | Actelion Pharmaceuticals US, Inc. ($72.42) |
| 2023 | $211.89 | 10 | Actelion Pharmaceuticals US, Inc. ($61.47) |
| 2022 | $195.73 | 8 | Amgen Inc. ($96.90) |
| 2021 | $82.72 | 4 | Novartis Pharmaceuticals Corporation ($43.49) |
| 2020 | $261.61 | 15 | Actelion Pharmaceuticals US, Inc. ($87.99) |
| 2019 | $246.16 | 14 | Novartis Pharmaceuticals Corporation ($58.01) |
| 2018 | $265.33 | 23 | PFIZER INC. ($139.52) |
| 2017 | $360.91 | 17 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($128.30) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Cardiology | ||||||
| 08/02/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Cardiology | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/03/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Cardiology | ||||||
| 04/19/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.89 | General |
| 03/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/29/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 02/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/12/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardiology | ||||||
| 11/17/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: DIABETES | ||||||
| 11/17/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Vascular | ||||||
| 11/10/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 10/07/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Cardiology | ||||||
| 07/14/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Cardiology | ||||||
| 07/01/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/09/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Cardiology | ||||||
| 05/23/2023 | Abbott Laboratories | JETI PERIPHERAL CATHETER (Device) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Vascular | ||||||
| 03/17/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/13/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 980 | 1,649 | $486,643 | $121,048 |
| 2022 | 11 | 953 | 1,704 | $503,718 | $114,797 |
| 2021 | 10 | 1,014 | 1,895 | $296,091 | $122,496 |
| 2020 | 11 | 1,090 | 1,786 | $250,199 | $104,892 |
Total Patients
4,037
Total Services
7,034
Medicare Billing
$463,233
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 137 | 454 | $163,896 | $49,319 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 228 | $114,200 | $25,358 | 22.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 123 | 135 | $94,770 | $21,362 | 22.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 113 | 117 | $28,080 | $6,877 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 38 | $26,098 | $5,453 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $21,960 | $4,167 | 19.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 247 | 400 | $11,667 | $2,824 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 31 | 31 | $7,438 | $1,855 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 22 | $8,241 | $1,615 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 60 | 99 | $6,506 | $1,305 | 20.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 50 | 60 | $1,790 | $409.36 | 22.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 15 | 16 | $1,100 | $294.24 | 26.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 16 | 17 | $897.00 | $208.25 | 23.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 116 | 389 | $141,662 | $36,829 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 115 | 260 | $141,235 | $28,761 | 20.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 107 | 120 | $82,985 | $21,366 | 25.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 108 | 111 | $42,996 | $6,513 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $25,103 | $5,758 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 37 | $27,444 | $5,749 | 20.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 289 | 533 | $13,625 | $3,830 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 24 | $9,642 | $1,966 | 20.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 56 | 102 | $7,251 | $1,291 | 17.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 18 | 18 | $4,529 | $1,135 | 25.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $5,461 | $1,090 | 20.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 46 | 50 | $1,294 | $364.72 | 28.2% |
About Dr. Richard Feldman, M.D
Dr. Richard Feldman, M.D is a Cardiovascular Disease healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992741151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Feldman, M.D has received a total of $1,926 in payments from pharmaceutical and medical device companies, with $301.95 received in 2024. These payments were reported across 105 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,905).
As a Medicare-enrolled provider, Feldman has provided services to 4,037 Medicare beneficiaries, totaling 7,034 services with total Medicare billing of $463,233. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Yonkers, NY
- Active Since 06/22/2006
- Last Updated 09/26/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1992741151
Products in Payments
- ELIQUIS (Drug) $239.49
- ENTRESTO (Drug) $237.94
- XARELTO (Drug) $208.97
- CHANTIX (Drug) $190.86
- LifeVest (Device) $178.75
- UPTRAVI (Drug) $159.93
- Repatha (Biological) $147.80
- OPSUMIT (Drug) $133.89
- LEQVIO (Drug) $74.42
- FARXIGA (Drug) $69.81
- VIAGRA (Drug) $37.53
- Hillrom - Carnation Ambulatory Monitor (Device) $36.75
- Inpefa (Drug) $24.40
- HeartMate 3 Left Ventricular Dev (Device) $22.18
- JARDIANCE (Drug) $22.09
- FUROSCIX (Drug) $21.91
- VERQUVO (Drug) $21.70
- JETI PERIPHERAL CATHETER (Device) $19.86
- MITRACLIP (Device) $19.81
- LOKELMA (Drug) $18.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Yonkers
Sachin Kumar Amruthlal Jain, M.d, M.D
Cardiovascular Disease — Payments: $19,903
Cardiovascular Disease $19,903
Sang Kim, M.d, M.D
Cardiovascular Disease — Payments: $8,929
Cardiovascular Disease $8,929
Dr. Douglas Hart, Md, MD
Cardiovascular Disease — Payments: $2,441
Cardiovascular Disease $2,441
Slawomir Malendowicz, Md, MD
Cardiovascular Disease — Payments: $2,431
Cardiovascular Disease $2,431
Dr. Gregory Neufeld, M.d, M.D
Cardiovascular Disease — Payments: $2,046
Cardiovascular Disease $2,046
Shahid Sheikh, M.d, M.D
Cardiovascular Disease — Payments: $1,178
Cardiovascular Disease $1,178